Olympus opts for Munich site for life sciences R&D (research and development) centre:
This article was originally published in Clinica
Japanese camera and medical products developer Olympus has opted to locate its new life science research and development centre in Munich, Germany. Tokyo-based Olympus will invest some Euro15m ($21m) in the project, which will be opened officially in October. By 2009, it will be employing a staff of 450, who will be involved in production as well as R&D in the fields of molecular diagnostics, laboratory automation and digital processing in microscopy. Olympus' regional HQ, Olympus Europa Holding, is located in Hamburg. The proximity of the University Hospital Grosshadern to the new Bavarian site was an advantage, said Olympus regional executive managing director Dr Helmut Kohler. The group will be working in close co-operation with the hospital.
You may also be interested in...
Medtronic says that most of the clinical trials it is sponsoring are paused due to the pandemic, which means the completion of its PMA application for the Symplicity Spyral renal denervation system will be delayed.
Three-month results of the SPYRAL HTN-OFF MED pivotal trial show renal denervation with Medtronic’s Symplicity Spyral system significantly reduced blood pressure in hypertensive patients not taking anti-hypertensive medications.
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”